查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836345

2032 年神经监测市场预测：按产品、模式、应用、最终用户和地区进行的全球分析

Neurology Monitoring Market Forecasts to 2032 - Global Analysis By Product, Modality, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球神经监测市场预计在 2025 年达到 108 亿美元，到 2032 年将达到 187 亿美元，预测期内的复合年增长率为 8.15%。

神经监测是指对神经系统功能进行持续或定期评估，以检测、评估和管理神经系统疾病。它使用先进的诊断工具，包括脑电图 (EEG)、肌电图 (EMG)、颅内压监测和脑血氧饱和度监测，追踪大脑、脊髓和周边神经活动。这种监测在重症加护、手术全期和慢性神经系统疾病中至关重要，能够及早发现异常，及时介入并改善患者预后。透过提供即时数据，神经监测支持明智的临床决策，并提高神经系统治疗的有效性。

神经系统疾病盛行率不断上升

神经系统疾病的日益流行，加速了医院和家庭护理机构对即时、非侵入性诊断工具的需求。癫痫、帕金森氏阿兹海默症、阿兹海默症和中风等疾病正在推动脑电图 (EEG)、肌电图 (EMG) 和颅内压监测仪的应用。与人工智慧 (AI) 和远端监控平台的整合正在提高诊断准确性和患者预后。人口老化和生活方式相关的神经系统风险正在扩大可治疗的患者群体。

先进监控设备高成本

先进监测设备的高成本降低了小型诊所和新兴市场的可负担性。安装、校准和维护费用限制了采购週期。神经系统诊断的报销和预算分配有限，阻碍了机构的采用。製造商必须在创新与成本效益之间取得平衡。这些限制因素阻碍了下一代监测平台的采用。

新兴国家医疗投资增加

新兴国家医疗保健投资的增加正在加速脑电图 (EEG)、肌电图 (EMG) 和脑血氧仪系统的部署。政府和私人医疗机构正在透过远端医疗和远端监控计划扩展神经病学能力。对神经系统疾病早期发现和长期管理的需求正在推动设备采购。本地製造和官民合作关係正在提高医疗服务的可负担性和服务水准。

不利的报销政策

不利的报销政策正在削弱医院和诊断中心的财务可行性。神经系统手术和设备的保险覆盖范围不一致，限制了病患的就医管道和医疗机构的奖励。围绕设备分类和使用通讯协定的监管模糊性正在减缓核准。支付系统碎片化和成本控制压力正在减少对先进监控基础设施的投资。这些因素正在减缓成本敏感型医疗保健系统的采用。

COVID-19的影响：

新冠疫情加速了对免疫支持和低糖产品的需求，并引发了人们对植物性甜味剂的兴趣。封锁措施和对健康的担忧使消费转向机能饮料和家庭自製食品。供应链中断暂时恶化了关键植物成分的可得性和采购。疫情后的復苏正在推动对本地生产和洁净标示创新的投资。数位零售和健康平台正在扩大消费者的获取管道和教育。这场危机推动了天然甜味剂从小众市场走向主流。

预测期内，脑电图 (EEG) 设备市场预计将成为最大的市场

脑电图 (EEG) 设备领域预计将在预测期内占据最大的市场份额，这得益于其在诊断和监测多种病症的脑活动方面的多功能性。癫痫、睡眠障碍和神经退化性疾病领域的应用正在推动其在机构和门诊环境中的应用。与携带式和云端连接格式的整合正在提高可用性和资料可存取性。医院、神经科科诊所和研究中心正在扩展其脑电图基础设施以进行即时分析。讯号处理和伪影消除技术的进步正在提高诊断的准确性。该领域仍是神经监测通讯协定的基石。

穿戴式脑电图设备领域预计将在预测期内实现最高复合年增长率

随着远端和持续脑监测需求的加速成长，穿戴式脑电图设备市场预计将在预测期内实现最高成长率。与行动应用程式、云端平台和人工智慧分析的整合正在扩大其在门诊病人和居家照护环境中的应用。睡眠追踪、癫痫发作检测和认知评估等领域的应用正在激发消费者和临床医生的兴趣。轻巧的外形规格和无线连接正在提高患者的舒适度和依从性。医疗科技公司与数位健康平台之间的伙伴关係正在推动认知度和普及度的提升。

占比最大的地区：

在预测期内，北美预计将占据最大的市场份额，这得益于其强大的医疗基础设施、较高的诊断意识以及优惠的报销框架。美国和加拿大正在扩大医院、研究机构和居家照护网路中的神经监测。对人工智慧诊断和远距神经病学平台的投资正在增强服务能力。与领先设备製造商的学术合作正在推动创新。监管的明确性和临床整合正在增强市场主导地位。该地区将继续成为神经诊断部署的标竿。

复合年增长率最高的地区：

由于医疗保健体系的不断扩展和神经系统疾病负担的不断加重，预计亚太地区在预测期内的复合年增长率最高。中国、印度、日本和东南亚正在透过公共卫生措施和私人投资推动神经监测的扩张。新兴经济体医疗保健投资的不断增加正在加速脑电图 (EEG)、肌电图 (EMG) 和脑血氧仪技术的普及。穿戴式装置和行动诊断领域的区域技术创新正在提高可负担性和普及性。对早期检测和长期照护的需求正在推动神经监测技术的快速普及。

免费客製化服务：

此报告的订阅者可以选择以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球神经监测市场（按产品）

  • 脑电图（EEG）
  • 脑磁图（MEG）
  • 颅内压监测仪（ICP）
  • 脑血氧测定
  • 经颅都卜勒（TCD）
  • 肌电图（EMG）
  • 诱发电位装置
  • 睡眠监测设备
  • 软体和分析平台
  • 耗材及配件

6. 全球神经监测市场（按模式）

  • 侵入式监测
  • 非侵入式监测

7. 全球神经监测市场（按应用）

  • 创伤性脑损伤（TBI）
  • 中风和脑血管疾病
  • 癫痫
  • 帕金森氏症
  • 阿兹海默症和失智症
  • 睡眠障碍
  • 多发性硬化症
  • ICU及加护治疗监测
  • 手术和术中监测
  • 研究和临床试验
  • 其他用途

8. 全球神经监测市场（依最终用户）

  • 医院
  • 神经科诊所
  • 门诊手术中心
  • 居家照护环境
  • 学术研究机构
  • 其他最终用户

9. 全球神经监测市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Medtronic plc
  • Natus Medical Incorporated
  • Philips Healthcare
  • Nihon Kohden Corporation
  • GE Healthcare
  • Compumedics Limited
  • Masimo Corporation
  • Siemens Healthineers
  • Cadwell Industries, Inc.
  • NeuroWave Systems Inc.
  • NeuraSignal Solutions
  • Micromed Group
  • Neurosoft
  • Electrical Geodesics, Inc.（EGI）
  • Integra LifeSciences Holdings Corporation
Product Code: SMRC31469

According to Stratistics MRC, the Global Neurology Monitoring Market is accounted for $10.8 billion in 2025 and is expected to reach $18.7 billion by 2032 growing at a CAGR of 8.15% during the forecast period. Neurology monitoring refers to the continuous or periodic assessment of the nervous system's function to detect, evaluate, and manage neurological conditions. It involves tracking brain, spinal cord, and peripheral nerve activity using advanced diagnostic tools such as electroencephalography (EEG), electromyography (EMG), intracranial pressure monitors, and cerebral oximetry. This monitoring is essential in critical care, perioperative settings, and chronic neurological disorders, enabling early detection of abnormalities, timely intervention, and improved patient outcomes. By providing real-time data, neurology monitoring supports informed clinical decisions and enhances the effectiveness of neurological treatments.

Market Dynamics:

Driver:

Rising prevalence of neurological disorders

Rising prevalence of neurological disorders is accelerating demand for real-time, non-invasive diagnostic tools across hospitals and home care settings. Conditions such as epilepsy, Parkinson's, Alzheimer's, and stroke are driving adoption of EEG, EMG, and intracranial pressure monitors. Integration with AI and remote monitoring platforms is improving diagnostic accuracy and patient outcomes. Aging populations and lifestyle-related neurological risks are expanding the addressable patient base.

Restraint:

High cost of advanced monitoring devices

High cost of advanced monitoring devices is degrading affordability for smaller clinics and emerging markets. Installation, calibration, and maintenance expenses are constraining procurement cycles. Limited reimbursement and budget allocation for neurological diagnostics are slowing institutional adoption. Manufacturers face pressure to balance innovation with cost efficiency. These constraints are delaying widespread deployment of next-generation monitoring platforms.

Opportunity:

Increased healthcare investments in emerging economies

Increased healthcare investments in emerging economies are accelerating deployment of EEG, EMG, and cerebral oximetry systems. Governments and private providers are scaling neurology capacity through telemedicine and remote monitoring initiatives. Demand for early detection and long-term management of neurological conditions is driving equipment procurement. Local manufacturing and public-private partnerships are improving affordability and reach.

Threat:

Unfavourable reimbursement policies

Unfavorable reimbursement policies are degrading financial viability for hospitals and diagnostic centers. Inconsistent coverage for neurology procedures and devices is limiting patient access and provider incentives. Regulatory ambiguity around device classification and usage protocols is slowing approvals. Fragmented payer systems and cost-containment pressures are reducing investment in advanced monitoring infrastructure. These factors are weakening adoption momentum in cost-sensitive healthcare systems.

Covid-19 Impact:

The Covid-19 pandemic accelerated demand for immunity-supporting and low-sugar products, boosting interest in plant-based sweeteners. Lockdowns and health concerns shifted consumption toward functional beverages and home-prepared meals. Supply chain disruptions temporarily degraded availability and sourcing of key botanical inputs. Post-pandemic recovery is fostering investment in localized production and clean-label innovation. Digital retail and wellness platforms are expanding consumer access and education. The crisis elevated natural sweeteners from niche to mainstream relevance.

The electroencephalography (EEG) devices segment is expected to be the largest during the forecast period

The electroencephalography (EEG) devices segment is expected to account for the largest market share during the forecast period due to their versatility in diagnosing and monitoring brain activity across multiple conditions. Applications in epilepsy, sleep disorders, and neurodegenerative diseases are driving institutional and outpatient adoption. Integration with portable and cloud-connected formats is improving usability and data access. Hospitals, neurology clinics, and research centers are scaling EEG infrastructure for real-time analysis. Advances in signal processing and artifact reduction are enhancing diagnostic precision. This segment remains the cornerstone of neurological monitoring protocols.

The wearable EEG devices segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the wearable EEG devices segment is predicted to witness the highest growth rate as demand for remote and continuous brain monitoring accelerates. Integration with mobile apps, cloud platforms, and AI analytics is expanding use in outpatient and home care settings. Applications in sleep tracking, seizure detection, and cognitive assessment are driving consumer and clinical interest. Lightweight form factors and wireless connectivity are improving patient comfort and compliance. Partnerships between medtech firms and digital health platforms are boosting visibility and adoption.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to strong healthcare infrastructure, high diagnostic awareness, and favorable reimbursement frameworks. United States and Canada are scaling neurology monitoring across hospitals, research institutions, and home care networks. Investment in AI-enabled diagnostics and tele-neurology platforms is enhancing service delivery. Presence of leading device manufacturers and academic collaborations is driving innovation. Regulatory clarity and clinical integration are reinforcing market dominance. The region remains the benchmark for neurodiagnostic deployment.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as healthcare systems expand and neurological disease burden rises. China, India, Japan, and Southeast Asia are scaling neurology monitoring through public health initiatives and private investment. Increased healthcare investments in emerging economies are accelerating access to EEG, EMG, and cerebral oximetry technologies. Local innovation in wearable formats and mobile diagnostics is improving affordability and reach. Demand for early detection and long-term care is driving rapid deployment.

Key players in the market

Some of the key players in Neurology Monitoring Market include Medtronic plc, Natus Medical Incorporated, Philips Healthcare, Nihon Kohden Corporation, GE Healthcare, Compumedics Limited, Masimo Corporation, Siemens Healthineers, Cadwell Industries, Inc., NeuroWave Systems Inc., NeuraSignal Solutions, Micromed Group, Neurosoft, Electrical Geodesics, Inc. (EGI) and Integra LifeSciences Holdings Corporation.

Key Developments:

In September 2025, Natus acquired the remaining minority shares of Holberg EEG, securing full ownership of its AI-powered EEG interpretation platform. The acquisition enables Natus to accelerate deployment of autoSCORE, a clinically validated model for routine, ambulatory, and long-term EEG diagnostics.

In July 2025, Medtronic and Philips announced a multi-year partnership to enhance patient monitoring technology. This collaboration aims to improve patient care and expand access to advanced monitoring solutions.

Products Covered:

  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
  • Intracranial Pressure Monitors (ICP)
  • Cerebral Oximeters
  • Transcranial Doppler (TCD)
  • Electromyography (EMG)
  • Evoked Potential Devices
  • Sleep Monitoring Devices
  • Software & Analytics Platforms
  • Consumables & Accessories

Modalities Covered:

  • Invasive Monitoring
  • Non-Invasive Monitoring

Applications Covered:

  • Traumatic Brain Injury (TBI)
  • Stroke & Cerebrovascular Disorders
  • Epilepsy
  • Parkinson's Disease
  • Alzheimer's & Dementia
  • Sleep Disorders
  • Multiple Sclerosis
  • ICU & Critical Care Monitoring
  • Surgical & Intraoperative Monitoring
  • Research & Clinical Trials
  • Other Applications

End Users Covered:

  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Academic & Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurology Monitoring Market, By Product

  • 5.1 Introduction
  • 5.2 Electroencephalography (EEG)
  • 5.3 Magnetoencephalography (MEG)
  • 5.4 Intracranial Pressure Monitors (ICP)
  • 5.5 Cerebral Oximeters
  • 5.6 Transcranial Doppler (TCD)
  • 5.7 Electromyography (EMG)
  • 5.8 Evoked Potential Devices
  • 5.9 Sleep Monitoring Devices
  • 5.10 Software & Analytics Platforms
  • 5.11 Consumables & Accessories

6 Global Neurology Monitoring Market, By Modality

  • 6.1 Introduction
  • 6.2 Invasive Monitoring
  • 6.3 Non-Invasive Monitoring

7 Global Neurology Monitoring Market, By Application

  • 7.1 Introduction
  • 7.2 Traumatic Brain Injury (TBI)
  • 7.3 Stroke & Cerebrovascular Disorders
  • 7.4 Epilepsy
  • 7.5 Parkinson's Disease
  • 7.6 Alzheimer's & Dementia
  • 7.7 Sleep Disorders
  • 7.8 Multiple Sclerosis
  • 7.9 ICU & Critical Care Monitoring
  • 7.10 Surgical & Intraoperative Monitoring
  • 7.11 Research & Clinical Trials
  • 7.12 Other Applications

8 Global Neurology Monitoring Market, By End User

  • 8.1 Hospitals
  • 8.2 Neurology Clinics
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Homecare Settings
  • 8.5 Academic & Research Institutes
  • 8.6 Other End Users

9 Global Neurology Monitoring Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic plc
  • 11.2 Natus Medical Incorporated
  • 11.3 Philips Healthcare
  • 11.4 Nihon Kohden Corporation
  • 11.5 GE Healthcare
  • 11.6 Compumedics Limited
  • 11.7 Masimo Corporation
  • 11.8 Siemens Healthineers
  • 11.9 Cadwell Industries, Inc.
  • 11.10 NeuroWave Systems Inc.
  • 11.11 NeuraSignal Solutions
  • 11.12 Micromed Group
  • 11.13 Neurosoft
  • 11.14 Electrical Geodesics, Inc. (EGI)
  • 11.15 Integra LifeSciences Holdings Corporation

List of Tables

  • Table 1 Global Neurology Monitoring Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Neurology Monitoring Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Neurology Monitoring Market Outlook, By Electroencephalography (EEG) (2024-2032) ($MN)
  • Table 4 Global Neurology Monitoring Market Outlook, By Magnetoencephalography (MEG) (2024-2032) ($MN)
  • Table 5 Global Neurology Monitoring Market Outlook, By Intracranial Pressure Monitors (ICP) (2024-2032) ($MN)
  • Table 6 Global Neurology Monitoring Market Outlook, By Cerebral Oximeters (2024-2032) ($MN)
  • Table 7 Global Neurology Monitoring Market Outlook, By Transcranial Doppler (TCD) (2024-2032) ($MN)
  • Table 8 Global Neurology Monitoring Market Outlook, By Electromyography (EMG) (2024-2032) ($MN)
  • Table 9 Global Neurology Monitoring Market Outlook, By Evoked Potential Devices (2024-2032) ($MN)
  • Table 10 Global Neurology Monitoring Market Outlook, By Sleep Monitoring Devices (2024-2032) ($MN)
  • Table 11 Global Neurology Monitoring Market Outlook, By Software & Analytics Platforms (2024-2032) ($MN)
  • Table 12 Global Neurology Monitoring Market Outlook, By Consumables & Accessories (2024-2032) ($MN)
  • Table 13 Global Neurology Monitoring Market Outlook, By Modality (2024-2032) ($MN)
  • Table 14 Global Neurology Monitoring Market Outlook, By Invasive Monitoring (2024-2032) ($MN)
  • Table 15 Global Neurology Monitoring Market Outlook, By Non-Invasive Monitoring (2024-2032) ($MN)
  • Table 16 Global Neurology Monitoring Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Neurology Monitoring Market Outlook, By Traumatic Brain Injury (TBI) (2024-2032) ($MN)
  • Table 18 Global Neurology Monitoring Market Outlook, By Stroke & Cerebrovascular Disorders (2024-2032) ($MN)
  • Table 19 Global Neurology Monitoring Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 20 Global Neurology Monitoring Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 21 Global Neurology Monitoring Market Outlook, By Alzheimer's & Dementia (2024-2032) ($MN)
  • Table 22 Global Neurology Monitoring Market Outlook, By Sleep Disorders (2024-2032) ($MN)
  • Table 23 Global Neurology Monitoring Market Outlook, By Multiple Sclerosis (2024-2032) ($MN)
  • Table 24 Global Neurology Monitoring Market Outlook, By ICU & Critical Care Monitoring (2024-2032) ($MN)
  • Table 25 Global Neurology Monitoring Market Outlook, By Surgical & Intraoperative Monitoring (2024-2032) ($MN)
  • Table 26 Global Neurology Monitoring Market Outlook, By Research & Clinical Trials (2024-2032) ($MN)
  • Table 27 Global Neurology Monitoring Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 28 Global Neurology Monitoring Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Neurology Monitoring Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 30 Global Neurology Monitoring Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 31 Global Neurology Monitoring Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 32 Global Neurology Monitoring Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 33 Global Neurology Monitoring Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 34 Global Neurology Monitoring Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.